Mutual Fund Details

DSP Healthcare Fund Direct - Growth

Equity Pharma

NAV

₹20.5670

as on 01 Jul 2022, 11:20 PM

₹0.1540(0.75%)

Last Change

Schemes Managed By

Vinit Sambre

Fund Manager

Chirag Dagli

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,96,548

₹2,06,020

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹1,06,020

Profit (absolute return)

106.02%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

11.12%

In the last 6 months

17.75%

In the last 1 year

9.95%

In the last 3 years

106.02%

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at high risk

Scheme Information

DSP Healthcare Fund Direct - Growth

as of 31 May 2022, 05:30 AM

₹1,178.57 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 12 months.

0.82%

Expense Ratio

Plan

Growth

0.00%

Cash Holding

Benchmark

S&P BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

S&P BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 12 months.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 May 2022

Sort By

Value

Sector

Insurance

2.42%

₹28.52 Cr

Capital Goods

1.63%

₹19.21 Cr

Others

95.95%

₹1,130.83 Cr

Sectors Holding in this Mutual Fund

as on 31 May 2022

Sort By

Value

Sector

Insurance

2.42%

₹28.52 Cr

Capital Goods

1.63%

₹19.21 Cr

Others

95.95%

₹1,130.83 Cr

Companies Holding in this Mutual Fund

as on 31 May 2022

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.85%

₹175.02 Cr

Cipla Ltd.

10.19%

₹120.10 Cr

Max Healthcare Institute Ltd.

7.79%

₹91.81 Cr

Apollo Hospitals Enterprise Ltd.

6.47%

₹76.25 Cr

Dr. Reddy's Laboratories Ltd.

6.21%

₹73.19 Cr

Others

54.49%

₹642.20 Cr

View All

Companies Holding in this Mutual Fund

as on 31 May 2022

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.85%

₹175.02 Cr

Cipla Ltd.

10.19%

₹120.10 Cr

Max Healthcare Institute Ltd.

7.79%

₹91.81 Cr

Apollo Hospitals Enterprise Ltd.

6.47%

₹76.25 Cr

Dr. Reddy's Laboratories Ltd.

6.21%

₹73.19 Cr

Others

54.49%

₹642.20 Cr

View All

Funds in this Category

This fund's returns:

27.22%

Return Duration

3 Years

Mirae Asset Healthcare Fund Direct - Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Nippon India Pharma Fund Direct-Growth

About DSP Healthcare Fund Direct - Growth

DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund managers Vinit Sambre and Chirag Dagli. It has an AUM of ₹1,178.57 Crores and the latest NAV decalared is ₹20.567 as on 04 Jul 2022 at 6:04 pm.

DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is -9.95%, in last 3 years is 106.02% and 104.57% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.